{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:30:00Z","timestamp":1771659000466,"version":"3.50.1"},"reference-count":191,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.seminhematol.2005.08.003","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"206-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Polycythemia Vera: Scientific Advances and Current Practice"],"prefix":"10.1053","volume":"42","author":[{"given":"Ayalew","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry L.","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2005.08.003_bib1","first-page":"384","article-title":"Sur une forme speciale de cyanose s\u2019accompagnant d\u2019hyperglobulie excessive et persistante","volume":"44","author":"Vaquez","year":"1892","journal-title":"CR Soc Biol (Paris)"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000441-190308000-00001","article-title":"Chronic cyanosis, with polycythemia and enlarged spleen","volume":"126","author":"Osler","year":"1903","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib3","first-page":"153","article-title":"Beitrage zur kenntnis des symptomenbildes polyzythamie mit milztumor und zyanose","volume":"17","author":"Turk","year":"1904","journal-title":"Wien Med Wochenschr"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib4","first-page":"357","volume":"21","author":"Low","year":"1910","journal-title":"Wien Med Wochenschr"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib5","first-page":"746","volume":"68","author":"Lesourd","year":"1910","journal-title":"Comptes Rendus Seances Soc Biol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.1930.00140160155014","article-title":"Peripheral arterial disease in polycythemia vera","volume":"46","author":"Brown","year":"1930","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7326\/0003-4819-10-10-1565","article-title":"The therapeutic use of venesection in polycythemia","volume":"10","author":"Stephens","year":"1937","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archinte.1938.00180170003001","article-title":"Course of polycythemia","volume":"62","author":"Rosenthal","year":"1938","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib9","first-page":"227","article-title":"Hematologic complications of P. vera","volume":"18","author":"Tinney","year":"1943","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0954-6820.1950.tb10111.x","article-title":"Polycythemia vera. Course and prognosis","volume":"138","author":"Videbaek","year":"1950","journal-title":"Acta Med Scand"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib11","first-page":"91","article-title":"Generalized osteosclerosis with chronic polycythemia vera","volume":"19","author":"Hirsch","year":"1935","journal-title":"Arch Pathol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","article-title":"Clonal origin of chronic myelocytic leukemia in man","volume":"58","author":"Fialkow","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib15","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib17","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood.V75.9.1770.1770","article-title":"Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms","volume":"75","author":"Tefferi","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib18","first-page":"871","article-title":"FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia","volume":"89","author":"Tefferi","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90133-7","article-title":"Chronic myeloid disorders","volume":"38","author":"Tefferi","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib20","unstructured":"Tefferi A, Gilliland DG: Classification of myeloproliferative disorders: From Dameshek towards a semi-molecular system. Best Pract Res Clin Haematol (in press)"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4065\/80.7.947","article-title":"The JAK2 V617F tyrosine kinase mutation in myeloproliferative disorders","volume":"80","author":"Tefferi","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib22","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2003-03-0885","article-title":"Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib23","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2004-09-3426","article-title":"Acute leukemia in polycythemia vera. An analysis of 1,638 patients enrolled in a prospective observational study","volume":"105","author":"Finazzi","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajh.2830090409","article-title":"Polycythemia vera in childhood","volume":"9","author":"Danish","year":"1980","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib25","first-page":"458","article-title":"Polycythemia vera","volume":"69","author":"Poggi","year":"1984","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib26","first-page":"935","article-title":"Primary polycythaemia in childhood and adolescence","volume":"110","author":"Heilmann","year":"1983","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib27","first-page":"159","article-title":"Epidemiological data in polycythaemia vera","volume":"40","author":"Najean","year":"1998","journal-title":"Hematol Cell Ther"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.1950.02910290018005","article-title":"Physiopathology and course of polycythemia vera as related to therapy","volume":"142","author":"Dameshek","year":"1950","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.patbio.2004.02.007","article-title":"A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP)","volume":"52","author":"Finazzi","year":"2004","journal-title":"Pathol Biol (Paris)"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2141.2001.03161.x","article-title":"Pruritus in polycythaemia vera","volume":"115","author":"Diehn","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00277-002-0593-x","article-title":"Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia","volume":"82","author":"Michiels","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2141.2002.03763.x","article-title":"Exploring polycythaemia vera with fluorescence in situ hybridization","volume":"119","author":"Najfeld","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cancergencyto.2003.09.011","article-title":"Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?","volume":"151","author":"Zamora","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2402980","article-title":"Molecular cytogenetics of polycythaemia vera","volume":"17","author":"Gribble","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<321::AID-GCC8>3.0.CO;2-X","article-title":"Gain of 9p in the pathogenesis of polycythemia vera","volume":"22","author":"Chen","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib38","first-page":"464","article-title":"Polycythemia vera","volume":"86","author":"Westwood","year":"2001","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib40","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/blood-2003-03-0744","article-title":"Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib43","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain of function mutation in Jak2 is frequently found in patients with myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and the myelodysplastic syndrome","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib47","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Bone-marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V84.6.1982.1982","article-title":"Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera","volume":"84","author":"Fisher","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1987.tb06158.x","article-title":"Erythropoietic colonies in a serum-free system","volume":"67","author":"Eridani","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.1994.tb03246.x","article-title":"Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression","volume":"86","author":"Dai","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","article-title":"Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3","volume":"87","author":"Dai","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V86.3.877.877","article-title":"Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera","volume":"86","author":"Mirza","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V59.2.447.447","article-title":"Erythroid progenitors in polycythemia vera","volume":"59","author":"Casadevall","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V52.6.1196.1196","article-title":"Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera","volume":"52","author":"Eaves","year":"1978","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V61.5.876.876","article-title":"Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny","volume":"61","author":"Cashman","year":"1983","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exphem.2003.11.003","article-title":"Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera","volume":"32","author":"Ugo","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2141.2002.03480.x","article-title":"The predictive value of clonogenic stem cell assays for the diagnosis of polycythaemia vera","volume":"117","author":"Zwicky","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.thj.6200344","article-title":"Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera","volume":"5","author":"Dobo","year":"2004","journal-title":"Hematol J"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib61","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.1988.00427.x-i1","article-title":"Megakaryocytic colony formation in polycythaemia vera and secondary erythrocytosis","volume":"69","author":"Juvonen","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1987.tb01293.x","article-title":"Colony formation by megakaryocytic progenitors in essential thrombocythaemia","volume":"66","author":"Juvonen","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0609.1989.tb01219.x","article-title":"Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders","volume":"42","author":"Battegay","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib64","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia","volume":"9","author":"Florensa","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib65","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1993.tb04688.x","article-title":"Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3","volume":"83","author":"Kobayashi","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib67","first-page":"311","article-title":"In vitro sensitivity of human erythroid progenitors to hemopoietic growth factors","volume":"79","author":"Montagna","year":"1994","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib68","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor","volume":"80","author":"Dai","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib69","first-page":"363a","article-title":"Hypersensitivity of polycythemia vera megakaryocytic progenitors to thrombopoietin","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0303-7207(01)00489-0","article-title":"Alterations of the insulin-like growth factor system in patients with polycythemia vera","volume":"181","author":"Michl","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib71","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V89.10.3574","article-title":"Polycythemia vera .5. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells\u2014A possible defect of phosphatase activity in polycythemia vera","volume":"89","author":"Dai","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.exphem.2004.10.017","article-title":"Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt\/PKB","volume":"33","author":"Dai","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib73","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI114303","article-title":"Erythropoietin receptors in polycythemia vera","volume":"84","author":"Means","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib74","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2141.1994.tb05119.x","article-title":"Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera","volume":"88","author":"Hess","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0145-2126(96)00002-1","article-title":"Analysis of the erythropoietin receptor gene in patients with myeloproliferative and myelodysplastic syndromes","volume":"20","author":"Mittelman","year":"1996","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib76","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood.V87.4.1502.bloodjournal8741502","article-title":"Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies","volume":"87","author":"Le Couedic","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib77","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1182\/blood.V79.11.3019.3019","article-title":"Familial and congenital polycythemia in three unrelated families","volume":"79","author":"Emanuel","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib78","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1046\/j.1365-2141.2001.03215.x","article-title":"Mutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia vera","volume":"115","author":"Li","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib79","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib80","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib81","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/path.1558","article-title":"Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders","volume":"203","author":"Bock","year":"2004","journal-title":"J Pathol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib82","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0609.2000.90235.x","article-title":"Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome","volume":"65","author":"Yoon","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib83","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/mp.52.3.146","article-title":"Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders","volume":"52","author":"Duensing","year":"1999","journal-title":"Mol Pathol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib84","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2003-03-0919","article-title":"Quantification of PRV-1 mRNA distinguishes Polycythemia vera from secondary erythrocytosis","volume":"102","author":"Klippel","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib85","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0404241101","article-title":"Mpl Baltimore","volume":"101","author":"Moliterno","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-2-8","article-title":"CD177","volume":"2","author":"Stroncek","year":"2004","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2141.2004.05098.x","article-title":"Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders","volume":"126","author":"Passamonti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib88","first-page":"3940","article-title":"Gene expression profiling in polycythemia vera using cDNA microarray technology","volume":"63","author":"Pellagatti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib89","first-page":"406","article-title":"Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates","volume":"90","author":"Sirhan","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2141.2003.04641.x","article-title":"The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders","volume":"123","author":"Bock","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib91","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.leu.2403700","article-title":"PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia","volume":"19","author":"Passamonti","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib92","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2002-07-2287","article-title":"Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0301-472X(01)00637-3","article-title":"STAT3 is constitutively active in some patients with Polycythemia rubra vera","volume":"29","author":"Roder","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib94","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood.V97.11.3424","article-title":"Increased expression of the INK4a\/ARF locus in polycythemia vera","volume":"97","author":"Dai","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib95","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/mend.16.4.0817","article-title":"PRL activates the cyclin D1 promoter via the Jak2\/Stat pathway","volume":"16","author":"Brockman","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a-\/-5b-\/- mice","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib97","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0960-9822(02)00930-2","article-title":"Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts","volume":"12","author":"Dolznig","year":"2002","journal-title":"Curr Biol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib98","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","article-title":"Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways","volume":"105","author":"Tong","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib99","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.onc.1200942","article-title":"The gene encoding hematopoietic cell phosphatase (Shp-1) is structurally and transcriptionally intact in polycythemia vera","volume":"14","author":"Asimakopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood.V90.2.651","article-title":"Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells","volume":"90","author":"Sui","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib101","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1182\/blood-2003-04-1308","article-title":"PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2141.1987.00285.x","article-title":"Polycythaemia vera in young people","volume":"67","author":"Najean","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib103","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s002770050505","article-title":"Development of erythrocytosis in the course of essential thrombocythemia","volume":"78","author":"Jantunen","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib104","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0609.1984.tb00671.x","article-title":"Polycythaemia following splenectomy in myelofibrosis with myeloid metaplasia. A reorganization of erythropoiesis","volume":"32","author":"Barosi","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.2830460312","article-title":"Familial myeloproliferative syndrome","volume":"46","author":"Perez-Encinas","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib106","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib107","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib108","first-page":"343","article-title":"Polycythemia vera","volume":"30","author":"Wasserman","year":"1954","journal-title":"Bull N Y Acad Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib109","doi-asserted-by":"crossref","first-page":"190a","DOI":"10.1182\/blood.V104.11.660.660","article-title":"Gender counts","volume":"104","author":"Spivak","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.thromres.2003.12.015","article-title":"Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera","volume":"112","author":"Bachleitner-Hofmann","year":"2003","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0002-9343(96)00351-8","article-title":"Inapparent polycythemia vera\u2014An unrecognized diagnosis","volume":"102","author":"Lamy","year":"1997","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib113","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","article-title":"Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy","volume":"304","author":"Berk","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib114","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.120.3.801","article-title":"Unexplained pulmonary hypertension in chronic myeloproliferative disorders","volume":"120","author":"Dingli","year":"2001","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-2007-996121","article-title":"Erythromelalgia and vascular complications in polycythemia vera","volume":"23","author":"Michiels","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib116","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib117","first-page":"483","article-title":"The treatment of polycythemia. A panel discussion","volume":"32","author":"Wasserman","year":"1968","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib118","first-page":"87","article-title":"The diagnostic criteria of polycythaemia rubra vera","volume":"22","author":"Pearson","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib119","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-996107","article-title":"Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group","volume":"23","author":"Michiels","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib120","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib121","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0037-1963(01)90136-2","article-title":"Evaluation of diagnostic criteria in polycythemia vera","volume":"38","author":"Pearson","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib122","series-title":"World health organization (WHO) Classification of Tumors","first-page":"32","article-title":"Polycythemia vera","author":"Pierre","year":"2001"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1078\/0344-0338-5710013","article-title":"Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients","volume":"197","author":"Thiele","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0001-2998(75)80005-5","article-title":"Blood volume","volume":"5","author":"Wright","year":"1975","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1365-2141.1995.tb08411.x","article-title":"Interpretation of measured red cell mass and plasma volume in adults","volume":"89","author":"Pearson","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib126","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2141.1973.tb01792.x","article-title":"Standard techniques for the measurement of red-cell and plasma volume. A report by the International Committee for Standardization in Hematology (ICSH)","volume":"25","year":"1973","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib127","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/bcmd.2000.0272","article-title":"Should whole-body red cell mass be measured or calculated?","volume":"26","author":"Balga","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/bcmd.2000.0275","article-title":"Commentary","volume":"26","author":"Fairbanks","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib129","first-page":"289","article-title":"An analysis of technical errors in radioalbumin blood volume methods and presentation of a modified method","volume":"52","author":"Hlad","year":"1958","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1152\/jappl.1987.63.3.1003","article-title":"Continuous monitoring of blood volume changes in humans","volume":"63","author":"Hinghofer-Szalkay","year":"1987","journal-title":"J Appl Physiol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib131","first-page":"422","article-title":"Effect of obesity on red cell mass results","volume":"40","author":"Leslie","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib132","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.21105","article-title":"Red cell mass and plasma volume measurements in polycythemia","volume":"104","author":"Sirhan","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2141.2002.03386.x","article-title":"Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia","volume":"117","author":"Messinezy","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib134","first-page":"1194","article-title":"Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis","volume":"89","author":"Mossuz","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0025-6196(12)61011-8","article-title":"Chromosome studies in 104 patients with polycythemia vera","volume":"66","author":"Diez-Martin","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib136","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4065\/78.2.174","article-title":"Polycythemia vera","volume":"78","author":"Tefferi","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib137","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2141.2004.05149.x","article-title":"Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders","volume":"127","author":"Koch","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib139","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00045391-200311000-00008","article-title":"Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase","volume":"10","author":"Alcocer","year":"2003","journal-title":"Am J Ther"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib140","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2002.11.507","article-title":"Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia","volume":"20","author":"Teofili","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib141","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2003-10-3502","article-title":"Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia","volume":"103","author":"Florensa","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib142","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0268-960X(87)90008-7","article-title":"The significance of endogenous erythroid colonies (EEC) in haematological disorders","volume":"1","author":"Reid","year":"1987","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib143","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet C-Mpl receptor in essential thrombocythemia","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib144","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/clinchem\/37.7.1178","article-title":"Rapid and specific enzyme immunoassay of serotonin","volume":"37","author":"Chauveau","year":"1991","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.0007-1048.2001.03302.x","article-title":"A novel immunocytochemical assay for the detection of serotonin in platelets","volume":"116","author":"Maurer-Spurej","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib146","first-page":"109","article-title":"Congenital polycythemias\/erythrocytoses","volume":"90","author":"Gordeuk","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib147","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1971.tb02698.x","article-title":"The management of polycythemia vera","volume":"21","author":"Wasserman","year":"1971","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0609.1984.tb02212.x","article-title":"Interpretation of measured red cell mass and plasma volume in males with elevated venous PCV values","volume":"33","author":"Pearson","year":"1984","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib149","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10245332.1999.11746463","article-title":"Myeloproliferative disease: Polycythemia vera: The packed cell volume and the curious logic of the red cell mass","volume":"4","author":"Fairbanks","year":"2000","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib150","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1172\/JCI102643","article-title":"The use of K42 or P32 labeled erythrocytes and I131 tagged human serum albumin in simultaneous blood volume determinations","volume":"31","author":"Berson","year":"1952","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib151","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/2005-129-89-AORCMA","article-title":"Analysis of red cell mass and plasma volume in patients with polycythemia","volume":"129","author":"Lorberboym","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib152","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1034\/j.1600-0609.2000.065005285.x","article-title":"Normal ranges for packed cell volume and hemoglobin concentration in adults","volume":"65","author":"Fairbanks","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib153","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4065\/79.3.430","article-title":"Polycythemia vera evaluation algorithm revisited","volume":"79","author":"Knutsen","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib154","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2141.2005.05517.x","article-title":"An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis","volume":"129","author":"Johansson","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0954-6820.1962.tb07186.x","article-title":"Complications and causes of death in polycythemia vera","volume":"172","author":"Chievitz","year":"1962","journal-title":"Acta Med Scand"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib156","series-title":"Polycythemia Vera and the Myeloproliferative Disorders","first-page":"147","article-title":"Early approaches in the treatment of polycythemia vera","author":"Gardner","year":"1995"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib157","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(64)90909-2","article-title":"Leukaemogenic effect of ionising-irradiation treatment in polycythaemia","volume":"67","author":"Osgood","year":"1964","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib158","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-196507000-00003","article-title":"Polycythemia vera and leukemia\u2013The role of radiation treatment. A study of 1222 patients","volume":"44","author":"Modan","year":"1965","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib159","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archinte.1967.00300030083016","article-title":"Autoimmune hemolytic anemia, acute leukemia, and carcinoma of the lung. Sodium phosphate P 32 treatment of polycythemia vera","volume":"120","author":"Holland","year":"1967","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib160","series-title":"Polycythemia Vera and the Myeloproliferative Disorders","first-page":"166","article-title":"Treatment of polycythemia vera","author":"Berk","year":"1995"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib161","first-page":"172","article-title":"Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera","volume":"23","author":"Tartaglia","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/bjc.1981.150","article-title":"Treatment of polycythaemia vera by radiophosphorus or busulphan","volume":"44","year":"1981","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib163","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V90.9.3370","article-title":"Treatment of polycythemia vera\u2014The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years","volume":"90","author":"Najean","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib164","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.V89.7.2319","article-title":"Treatment of polycythemia vera","volume":"89","author":"Najean","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib166","first-page":"17","article-title":"From efficacy to safety\u2014A Polycythemia Vera Study Group report on hydroxyurea in patients with polycythemia vera","volume":"34","author":"Fruchtman","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib167","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","article-title":"Anonymous: Anagrelide, a therapy for thrombocythemic states: Experience in 577 patients","volume":"92","year":"1992","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib168","first-page":"40","article-title":"Interferon alfa","volume":"34","author":"Silver","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib169","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.leu.2402938","article-title":"Imatinib mesylate (Gleevec) reduces phlebotomy requirements in polycythemia vera","volume":"17","author":"Silver","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib170","first-page":"1394","article-title":"Anagrelide-associated cardiomyopathy in polycythemia vera and essential thrombocythemia","volume":"89","author":"Jurgens","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib171","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-2007-996123","article-title":"Interferon-alpha therapy in polycythemia vera and essential thrombocythemia","volume":"23","author":"Elliott","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib172","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0609.2004.00351.x","article-title":"Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib","volume":"74","author":"Breccia","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib173","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2003-07-2323","article-title":"Fatal hepatic necrosis following imatinib mesylate therapy","volume":"102","author":"Lin","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib174","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood.V104.11.6.6","article-title":"The medical research council PT1 trial in essential thrombocythemia","volume":"104","author":"Green","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib175","first-page":"30","article-title":"Influence of therapy on causes of death in polycythemia vera","volume":"94","author":"Wasserman","year":"1981","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib176","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-0609.2005.00424.x","article-title":"Management of patients with polycythaemia vera","volume":"74","author":"Andreasson","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib177","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V99.4.1144","article-title":"The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group","volume":"99","author":"Streiff","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib178","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand\u2019s disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib179","first-page":"211","article-title":"Hydroxyurea vindicated","volume":"4","author":"Tefferi","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib180","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0950-3536(98)80043-7","article-title":"Fertility, pregnancy and the management of myeloproliferative disorders","volume":"11","author":"Griesshammer","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib181","first-page":"1011","article-title":"Efficacy of pipobroman in the treatment of polycythemia vera","volume":"85","author":"Passamonti","year":"2000","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib182","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V99.7.2627","article-title":"Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus","volume":"99","author":"Tefferi","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib183","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0140-6736(91)92206-H","article-title":"Alpha-interferon for intractable pruritus in polycythaemia vera","volume":"337","author":"de Wolf","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib184","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.2002.03287.x","article-title":"The optimal management of polycythaemia vera","volume":"116","author":"Spivak","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib185","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","article-title":"Identification of \u2018short-lived\u2019 and \u2019long-lived\u2019 patients at presentation of idiopathic myelofibrosis","volume":"97","author":"Cervantes","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib186","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera","volume":"123","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib187","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00005792-198211000-00004","article-title":"Non-hematologic effects of chronic iron deficiency. A study of patients with polycythemia vera treated solely with venesections","volume":"61","author":"Rector","year":"1982","journal-title":"Medicine"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib188","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2141.1985.tb02880.x","article-title":"Treatment of primary proliferative polycythaemia by venesection and low dose busulphan","volume":"61","author":"Messinezy","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib189","first-page":"261","article-title":"Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders","volume":"90","author":"Randi","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajh.2830340108","article-title":"Leukemic transformation in polycythemia vera","volume":"34","author":"Nand","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2005.08.003_bib191","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br J Haematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196305001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:17:10Z","timestamp":1758521830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196305001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":191,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0037196305001459"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.08.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycythemia Vera: Scientific Advances and Current Practice","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}